Ilya Petrou, MD, is a contributing writer for Dermatology Times.
Physicians take critical look at AJCC staging system, melanoma prognostication tool
September 1st 2012The latest melanoma staging system from the American Joint Committee on Cancer (AJCC) and a tool developed for predicting the clinical outcome of individual patients with localized or regional cutaneous melanoma (www.melanomaprognosis.org) have stirred debate among dermatopathologists.
Merkel cell carcinoma therapy depends on tumor stage, patient health
August 1st 2012Merkel cell carcinoma (MCC) is a neuroendocrine tumor of the skin that is very aggressive and potentially lethal. As such, treatment approaches and disease management should also be aggressive and appropriately address the patient's disease and symptoms. Treatment choices depend on the stage of the tumor, however, as well as the general health of the affected patient.
Tangential biopsy can exact accurate diagnosis of melanonychia
August 1st 2012A tangential biopsy performed on melanonychia may often be the superior biopsy technique in exacting an accurate diagnosis of suspect lesions, according to Nilton Di Chiacchio, M.D., department of dermatology, Hospital of Public Service, Sao Paulo.
Nd:YAG laser with temperature control clears onychomycosis
August 1st 2012A new laser approach is proving highly effective in the treatment of onychomycosis, offering patients a new therapeutic option for this sometimes difficult-to-treat condition, said Jill S. Waibel, M.D., at the 2012 meeting of the American Society for Laser Medicine and Surgery.
Androgenetic alopecia care with customized technique allows optimal outcomes
August 1st 2012With regard to the surgical treatment of androgenetic alopecia, strip harvesting and follicular unit extraction (FUE) techniques can work very well, but each technique must be used appropriately and for the appropriate patients to ensure optimal outcomes, says Walter Unger, M.D.
SLNB effective for disease-free survival in select cases
August 1st 2012Sentinel lymph node biopsy (SLNB) for management of localized primary melanoma continues to have its critics, but Alistair Cochran, M.D., says that current data supports the procedure as a standard approach for staging patients with clinically localized, intermediate-thickness melanoma.
Trial shows benefits to immediate lymph node dissection in some melanoma cases
July 1st 2012The results of the first Multicenter Selective Lymphadenectomy Trial (MSLT-1) seem to indicate that survival in patients with intermediate thickness melanoma and metastatic disease in the regional nodes can be improved if early lymph node dissection is performed when a positive sentinel node is identified.
Fractional bipolar radiofrequency device achieves marked tightening, lifting
July 1st 2012A facial rejuvenation device that delivers fractional bipolar radiofrequency (RF) energy via microneedling directly into the dermis tightens skin and achieves measurable lifting and volume increase the likes of which have never been seen by any other devices on the market, said Lori Brightman, M.D., at the 2012 meeting of the American Society for Laser Medicine and Surgery.
Leg hairs serve as novel way to restore thinning hairline
July 1st 2012Leg hairs can be a convenient and natural-looking donor source for hair transplantation when restoring a thinning hairline. This approach offers an aesthetic solution for select patients with male pattern baldness, according to one hair transplant specialist.
Pegylated, standard interferon retain relevance in some melanoma cases
June 1st 2012Interferon and the recently Food and Drug Administration-approved pegylated interferon remain relevant adjuvant therapies for patients with lymph node-positive melanoma, even in light of advances with CTLA4 blockade and BRAF-targeted therapies for late-stage disease, says Vernon K. Sondak, M.D., chairman, department of cutaneous oncology, Moffitt Cancer Center, Tampa, Fla.
Suspected melanonychia in pediatric patients can confound physicians
June 1st 2012Differentiating benign nail pigmentations such as melanonychia from either nail or nail matrix melanoma is especially difficult in children because pediatric lesions present differently than they do in adults, according to Antonella Tosti, M.D., professor of the department of dermatology and cutaneous surgery, University of Miami Miller School of Medicine.
DermaSculpt laser: Ablation of small cutaneous lesions made easy
January 1st 2010An Er:YAG laser equipped with tiny, straight and curved micron tips allows physicians to perform ablative treatments of very small and typically hard-to-reach cutaneous lesions more quickly and easily compared to traditional straight tips.
Zinc a zero: Rosacea unresponsive to dietary supplementation, trial indicates
December 1st 2009A recent clinical trial found that the dietary supplementation of oral zinc sulfate is ineffective in treating patients suffering from moderate-to-severe rosacea. The apparent failure of this particular clinical trial is of particular interest in that it was a near-duplicate of a 3-year-old clinical trial found in the literature, which showed that oral zinc supplementation was beneficial in the treatment of rosacea.